COl is a small family comprising 5 MOC-Iike genes located on chromosome 1 and encoding glycoproteins termed COla, COlb, COlc, COld and COle. They are expressed mainly on the surface of dendritic cells, monocytes and some thymocytes and are specialized in presenting lipid antigens to T lymphocytes. The structure is similar to that of MOC class I molecules with 3 globular domains and the p2-microglobulin. It has been shown that all five human COl genes exhibit a limited number of polymorphisms in the alphal domain whose effects are still unknown. COle results to be the most polymorphic isoform with six COle alleles (01, 02 in exon 2 and 03, 04, 05, 06 in ex3) described to date. At this moment, few investigations on the allele frequencies of the COl genes have been reported and all additional information improves our knowledge on this new class of antigen-presenting molecules. In order to study possible allelic variations of exon 2 of human COla and COle genes, we analyzed, by a sensitive technique, the sequence-based typing (SBT), 114 ONA samples from unrelated healthy Italian individuals from the Abruzzo region. Our experimental findings indicate that the allele frequency distribution of both COla and COle genes is in accordance with that observed in other geographic areas and did not identify any new allele, thus confirming a very low polymorphism.
For many years MHC class I and II molecules have represented the unique type of antigenpresenting molecules to T lymphocytes. Recently, the increasing interest in a novel class of molecules, the CD I glycoproteins, has permitted the identification ofother mechanisms for specific antigen presentation to T cells (1-2).
CD I genes are present in all mammalian species studied to date and have diverged from the common ancestor at nearly the same time point when the two separated MHC class I and II lineages diverged, as proposed by Ulrich and Porcelli (3) .
It is possible to distinguish 5 CD 1 isoforms separated into two groups: I) CD Ia, b, c that present both selfand foreign lipids to the T cells and 2) CD 1d that presents self lipids to specialized NKT cells. The fifth isoform CD 1e would be in an intermediate position between the two groups and would help to expand the repertoire of glycolipid T cell antigens to optimize antimicrobial immune responses (4).
All five CD I isofonns are characterized by an intron-exon structure similar to that of MHC molecules, with a heavy chain consisting of u l , a2 and a3 domains non covalently associated with~2 microglobulin. Between the 2 alpha helixes of the ul and a2 domains there is the binding-groove with an opening above two hydrophobic pockets named F and A that captures the lipid antigens (5) (6) .
In previous papers the level of polymorphism of the human CD I gene that resulted low was extensively analyzed (7) (8) . It was reported that all five loci are polymorphic in ul domain with, at present, two alleles described for CD Ia, -b, -c, and -d loci and six alleles for CD Ie locus.
In the case of CD Ib and CD Ic, the allelic forms differed from the wild-type by one silent point mutation, while polymorphisms in COla, -d and CD Ie loci result in single amino acid substitutions (9) .
The objectives of this study are: i) to evaluate the distribution of the frequency of the CD 1a and CD Ie genes in a population of the Abruzzo region; ii) to examine the polymorphisms existing in exon 2 of the CD Ia and e genes using the polymerase chain reaction (PCR) amplification and a new sequencebased typing (SBT) approach.
To date no other similar studies in Italy are available on this topic and our work pennits us to increase knowledge of the polymorphism in CD Ia and CD Ie genes that may be functionally significant considering the location of the aminoacidic substitutions. Furthermore, this study compares and confirms the data published for other European populations and may be of great interest in understanding the role of these polymorphisms for clinical aims and diseases.
MATERIALS AND METHODS

Population sample
One hundred and fourteen unrelated randomly selected healthy subjects from the same geographic area (the Abruzzo region) were consecutively enrolled in the study over the period 2004/2006: 59 were males and 55 females; the mean age was 27.5 yrs (range 20-35). All participants were hematopoietic stem cell donors who attended the Regional Center for Immunohaematology and Tissue Typing L'Aquila, Italy. Written informed consent was obtained from each participant involved in the study and the study was approved by the local Ethics Committee.
The estimate of sample size was performed using the following parameters: Abruzzo region census population (1,285,896) (www.demo.ISTAT.it).CDla*02 allele frequency, (8) , sample error E=0.04, probability 1-(1=0.95.
DNA extraction
DNA was extracted according to the protocol of the manufacturer (QIAamp DNA blood MiniKit, Qiagen, Courtaboeuf, France) and kept at -20°C until use. DNA concentration was determined at 260 nm using a spectrophotometer (Beckman Instruments, Inc. Fullerton, CA. 92834-3100). The ratio 260/280 was measured to evaluate DNA purity.
All individuals had been previously HLA class I and class II typed at low resolution.
SBTdesign
Direct sequencing used in this study required several steps.
First step
DNA segments corresponding to exon 2 ofCDIA and -E genes were PCR amplified from genomic DNA using the primers shown in Table I .
PCR amplifications were carried out on 50 ng genomic DNA in a 50 ml volume containing I xPCR buffer with MgCI2, 0.2 mM each of deoxynucleotides, 0.5 U of Taq polymerase, the buffer provided and an optimised primer concentration. DNA samples were amplified in a GeneAmp PCRsystem 9600 (Perkin-Elmer, Foster City, CA, USA).
Cycle parameters were the following: 5 min denaturation at 95°C, 30 cycles of 95°C for 20 s, 60°C for 30 s, noc for 30 s, and a final elongation cycle of noc for 5 min.
PCR products were electrophoresed in 1.5% agarose gel containing 0.5 mg/ml ethidium bromide.
Second step
PCR products were previously purified by Qiaquick columns and then sequenced in forward and reverse directions, using the Bigdye Terminator chemistry v. 3.1 (Applied Biosystems, Foster City, CA).
Gel electrophoresis analysis of the sequencing products was performed in a 3100 Genetic Analyzer (Applied Biosystems).
Third step
Purification of the sequenced products was performed by Centrisep spin columns.
Fourth step
The obtained sequences were analyzed by the Assign SBT Version 3.2.4 software (Conexio Genomics, Applecross, Western Australia) which detects the heterozygous positions within each electropherogram, and assesses the typing on the basis of an alignment of the processed sequence with the sequences for exon 2 of the human CD I a and CDI e genes retrieved from GenBank.
Statistical analysis
Hardy-Weinberg equilibrium (HWE) depends on a series of assumptions about the tested population, including, for example, no new mutation, no selection, and random mating. Departures from HWE, if not due to chance or violation of these assumptions, therefore may point to genotyping error or other biases.
HWE was evaluated using Conighi G. method (10) .
RESULTS
In this work, a new sequence-based typing (SBT) strategy was used to study the polymorphisms situated in exon 2 of CD 1a and CD 1e genes.
The results of CD 1a and CD Ie allele frequencies (afs) of the population studied are listed in Table  II where the results of previous studies of other European Caucasian and North American populations were also reported.
CDla*02 containing a C both at aminoacidic position 13 and 51, was found to be the more common CDla allele with a frequency of 0.99, instead, the CDla*OI was rarest; in fact it was detected only in one sample. With regard to the CD Ie gene, the first allele CD Ie*O I characterized by the presence of an A in codon 79, was found to be the more common CDle allele with a frequency of 0.74. The second allele CD Ie*02 that has a nucleotide substitution in codon 79 from A to G, had a frequency of 0.26.
The HWE was respected by the sample group for both the CD I genes.
In spite of the high-resolution typing level used in this work, no new CD Ia and CD Ie alleles were found inside the studied group, as evidence of their very low polymorphism.
DISCUSSION
CD I glycoproteins are highly conserved molecules characterized by an extremely low level of allelic polymorphism, probably due to their ability of presenting lipidic antigens that result less variable than the peptides presented by classic MHC molecules to T lymphocytes, as indicated by Oteo et al. (8) .
The functional effects of CD I polymorphisms are still unknown; many works relate that the CD I system has a role in the pathogenesis of certain diseases like the mycobacterial infections seeing as it presents mycobacteria-derived lipids (II). However, it seems likely that other pathogenic microbes are also recognized by this system (12) . Infact, lipides like peptides from microbial proteins that have sufficient structural simililarity with selfpeptides/lipides can activate autoreactive T cells, a mechanism that is called "molecular mimicry".
In order to establish the association ofthese genes with autoimmune diseases or diseases of chronic inflammation, the application ofa more sophisticated analysis is necessary than those available until now that have analyzed the allelic polymorphism of CD I genes with different methodologies in small groups of individuals from Europe, Africa and China (8) (9) .
For this reason, the principal aim of our study is to report a new sequence-based typing (SBT) approach that permits the study, at a high-resolution level, of the polymorphisms existing in CD Ia and CD Ie genes in a population selected for its geographic position. Moreover, this work can offer a contribution for better understanding the role of these molecules in the genetic susceptibility to autoimmune diseases. Regarding CD 1allele distribution, our study is the first that has been carried out in a population of the Abruzzo region (central Italy). Our results show that the most frequent CDla allele was CDla*02 (99%). Similar frequencies have been reported for both UK and European Caucasian populations (95%) (8, II). However, a lower frequency for this allele has been recorded in other North America populations (87%) (9) . The most frequent CD 1e allele was CD Ie*O 1 (74%) and this result was similar to findings for the UK population (67%), but higher than North American populations (49%) (9) . Another important difference between our population and North American populations is the lower percentage of CD 1e*02, respectively: 26% and 51% (Table II) .
In conclusion, this study confirms the existence of two allelic forms for each of the CD 1 molecules which have already been evidenced in the other European populations that have been studied.
Moreover, studies of CD 1 polymorphism in various ethnic groups, such as ours, may contribute to determine whether CD l-restricted T cell response to non-peptide antigens is significantly involved in protective immune responses to population/ecologyspecific microbial pathogens.
